In preclinical investigations, CDK4/6 inhibitors have enhanced apoptosis, caused cellular senescence, reduced DNA damage repair, and arrested the cell cycle, all of which have radiosensitized cancer cells (Franco et al. 2023). This evidence concerns the gene CDK4 and cancer.